Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹1296 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -0.28% | -0.81% |
6 Month | 7.77% | 9.63% |
1 Year | -3.75% | -1.89% |
3 Year | 20.47% | 22.87% |
5 Year | - | 17.27% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 1.52% | 2.29% |
1 Year | 4.66% | 8.59% |
3 Year | 18.57% | 20.85% |
5 Year | - | 18.29% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 18.94% | 9.76% |
3 Year | 20.21% | 18.6% |
5 Year | - | 15.32% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.65% | 16.05% |
Sharp | 0.78% | 0.90% |
Beta | 0.95% | 0.98% |
Alpha | -2.36% | -0.49% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.23 | 4.61 |
Large Cap | 29.73 | 28.41 |
Mid Cap | 37.1 | 35.03 |
Small Cap | 28.95 | 31.95 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.13 | 2.56 |
Healthcare | 90.65 | 94.45 |
Basic Materials | 3.99 | 1.44 |
Industrials | 1.99 | - |
Financial Services | 1.24 | 1.56 |
Top Comparisons
SBI US Specific Equity Active FoF - Regular Plan - Growth
3Y Returns25.5%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns38.75%
HDFC Mid-Cap Fund - Growth Plan
3Y Returns26.24%
PGIM India Midcap Fund - Regular Plan - Growth Option
3Y Returns13.97%
Sundaram Arbitrage Fund Regular Growth
3Y Returns6.64%
Invesco India Arbitrage Fund - Growth Option
3Y Returns7.12%
Nippon India Ultra Short Duration Fund- Growth Option
3Y Returns6.95%
HSBC Ultra Short Duration Fund - Regular Growth
3Y Returns7.18%